Literature DB >> 26149011

Pathogen activators of plasminogen.

I M Verhamme1, P R Panizzi2, P E Bock1.   

Abstract

Group A streptococci (GAS) express soluble and surface-bound virulence factors. Secreted streptokinase (SK) allelic variants exhibit varying abilities to activate host plasminogen (Pg), and GAS pathogenicity is associated with Pg activation and localization of the resulting plasmin (Pm) on the bacterial surface to promote dissemination. The various mechanisms by which GAS usurp the host proteolytic system are discussed, including the molecular sexuality mechanism of conformational activation of the Pg zymogen (Pg*) and subsequent proteolytic activation of substrate Pg by the S•KPg* and SK•Pm catalytic complexes. Substantial progress has been made to delineate both processes in a unified mechanism. Pm coats the bacteria by direct and indirect binding pathways involving plasminogen-binding group A streptococcal M-like (PAM) protein and host fibrin(ogen). Transgenic mouse models using human Pg are being optimized to mimic infections by SK variants in humans and to define in vivo combined mechanisms of these variants and PAM.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  enzymology; fibrinolysis; plasminogen; streptococcus; streptokinase

Mesh:

Substances:

Year:  2015        PMID: 26149011      PMCID: PMC4498406          DOI: 10.1111/jth.12939

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  59 in total

Review 1.  Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues.

Authors:  M A Parry; X C Zhang; I Bode
Journal:  Trends Biochem Sci       Date:  2000-02       Impact factor: 13.807

2.  Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation.

Authors:  Rainer Friedrich; Peter Panizzi; Pablo Fuentes-Prior; Klaus Richter; Ingrid Verhamme; Patricia J Anderson; Shun-Ichiro Kawabata; Robert Huber; Wolfram Bode; Paul E Bock
Journal:  Nature       Date:  2003-10-02       Impact factor: 49.962

Review 3.  Molecular basis of group A streptococcal virulence.

Authors:  A L Bisno; M O Brito; C M Collins
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

4.  Domain interactions between streptokinase and human plasminogen.

Authors:  J A Loy; X Lin; M Schenone; F J Castellino; X C Zhang; J Tang
Journal:  Biochemistry       Date:  2001-12-04       Impact factor: 3.162

5.  Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.

Authors:  Hongmin Sun; Ulrika Ringdahl; Jonathon W Homeister; William P Fay; N Cary Engleberg; Angela Y Yang; Laura S Rozek; Xixi Wang; Ulf Sjöbring; David Ginsburg
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

6.  Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations.

Authors:  Awdhesh Kalia; Debra E Bessen
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

7.  Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms.

Authors:  Jinmo Khil; Michael Im; Andrew Heath; Ulrika Ringdahl; Lakshmi Mundada; N Cary Engleberg; William P Fay
Journal:  J Infect Dis       Date:  2003-08-05       Impact factor: 5.226

8.  Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae.

Authors:  Simone Bergmann; Daniela Wild; Oliver Diekmann; Ronald Frank; Dagmar Bracht; Gursharan S Chhatwal; Sven Hammerschmidt
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

9.  Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase.

Authors:  Paul D Boxrud; Ingrid M Verhamme; Paul E Bock
Journal:  J Biol Chem       Date:  2004-06-23       Impact factor: 5.157

10.  Coupling of conformational and proteolytic activation in the kinetic mechanism of plasminogen activation by streptokinase.

Authors:  Paul D Boxrud; Paul E Bock
Journal:  J Biol Chem       Date:  2004-06-23       Impact factor: 5.157

View more
  7 in total

Review 1.  N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.

Authors:  Lucia F Zacchi; Benjamin L Schulz
Journal:  Glycoconj J       Date:  2015-12-05       Impact factor: 2.916

2.  Pathogenic conversion of coagulase-negative staphylococci.

Authors:  Wenqi Yu; Hwan Keun Kim; Sabine Rauch; Olaf Schneewind; Dominique Missiakas
Journal:  Microbes Infect       Date:  2016-12-21       Impact factor: 2.700

Review 3.  Single-chain factor XII: a new form of activated factor XII.

Authors:  Ivan Ivanov; Anton Matafonov; David Gailani
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

4.  Spiroplasma eriocheiris Invasion Into Macrobrachium rosenbergii Hemocytes Is Mediated by Pathogen Enolase and Host Lipopolysaccharide and β-1, 3-Glucan Binding Protein.

Authors:  Mingxiao Ning; Yunji Xiu; Meijun Yuan; Jingxiu Bi; Libo Hou; Wei Gu; Wen Wang; Qingguo Meng
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

5.  The fibrinolytic system enables the onset of Plasmodium infection in the mosquito vector and the mammalian host.

Authors:  Thiago Luiz Alves E Silva; Andrea Radtke; Amanda Balaban; Tales Vicari Pascini; Zarna Rajeshkumar Pala; Alison Roth; Patricia H Alvarenga; Yeong Je Jeong; Janet Olivas; Anil K Ghosh; Hanhvy Bui; Brandon S Pybus; Photini Sinnis; Marcelo Jacobs-Lorena; Joel Vega-Rodríguez
Journal:  Sci Adv       Date:  2021-02-05       Impact factor: 14.136

6.  Lysine Residues in the MK-Rich Region Are Not Required for Binding of the PbsP Protein From Group B Streptococci to Plasminogen.

Authors:  Francesco Coppolino; Letizia Romeo; Giampiero Pietrocola; Germana Lentini; Giuseppe Valerio De Gaetano; Giuseppe Teti; Roberta Galbo; Concetta Beninati
Journal:  Front Cell Infect Microbiol       Date:  2021-09-08       Impact factor: 5.293

Review 7.  Immunohaemostasis: a new view on haemostasis during sepsis.

Authors:  Xavier Delabranche; Julie Helms; Ferhat Meziani
Journal:  Ann Intensive Care       Date:  2017-12-02       Impact factor: 6.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.